AAAAAA

   
Results: 1-8 |
Results: 8
SENSITIZATION OF RAT GLIOBLASTOMA-MULTIFORME TO CISPLATIN IN-VIVO FOLLOWING RESTORATION OF WILD-TYPE P53 FUNCTION
Authors: DORIGO O TURLA ST LEBEDEVA S GJERSET RA
Citation: O. Dorigo et al., SENSITIZATION OF RAT GLIOBLASTOMA-MULTIFORME TO CISPLATIN IN-VIVO FOLLOWING RESTORATION OF WILD-TYPE P53 FUNCTION, Journal of neurosurgery, 88(3), 1998, pp. 535-540
CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY
Authors: FAKHRAI H SHAWLER DL VANBEVEREN C LIN H DORIGO O SOLOMON MJ GJERSET RA SMITH L BARTHOLOMEW RM BOGGIANO CA GOLD DP SOBOL RE
Citation: H. Fakhrai et al., CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY, Journal of immunotherapy, 20(6), 1997, pp. 437-448
TUMOR-REGRESSION IN-VIVO FOLLOWING P53 COMBINATION THERAPY
Authors: GJERSET RA DORIGO O MAUNG V LEBEDEVA S
Citation: Ra. Gjerset et al., TUMOR-REGRESSION IN-VIVO FOLLOWING P53 COMBINATION THERAPY, Cancer gene therapy, 4(6), 1997, pp. 2-2
P53 SUPPRESSION POTENTIATED BY INHIBITION OF AP-1 PHOSPHORYLATION
Authors: TURLA ST POTAPOVA O LEBEDEVA S HAGHIGHI A BOST F MERCOLA D GJERSET RA
Citation: St. Turla et al., P53 SUPPRESSION POTENTIATED BY INHIBITION OF AP-1 PHOSPHORYLATION, Cancer gene therapy, 3(6), 1996, pp. 77-77
ENHANCEMENT OF ANTITUMOR EFFECTS OF P53 GENE-THERAPY BY COMBINATION WITH DNA-DAMAGING AGENTS
Authors: HARPER ME CRISTIANO R SPITZ F NGUYEN D GJERSET RA ROTH JA
Citation: Me. Harper et al., ENHANCEMENT OF ANTITUMOR EFFECTS OF P53 GENE-THERAPY BY COMBINATION WITH DNA-DAMAGING AGENTS, Cancer gene therapy, 3(6), 1996, pp. 114-114
CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSESMUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY
Authors: GJERSET RA FAKHRAI H SHAWLER DL TURLA S DORIGO O GROVERBARDWICK A MERCOLA D WEN SF COLLINS H LIN H GARCIA MV KRUSE CA ROYSTON I SOBOL RE
Citation: Ra. Gjerset et al., CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSESMUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY, In vitro cellular & developmental biology. Animal, 31(3), 1995, pp. 207-214
COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA
Authors: SHAWLER DL DORIGO O GJERSET RA ROYSTON I SOBOL RE FAKHRAI H
Citation: Dl. Shawler et al., COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 17(4), 1995, pp. 201-208
USE OF WILD-TYPE P53 TO ACHIEVE COMPLETE TREATMENT SENSITIZATION OF TUMOR-CELLS EXPRESSING ENDOGENOUS MUTANT P53
Authors: GJERSET RA TURLA ST SOBOL RE SCALISE JJ MERCOLA D COLLINS H HOPKINS PJ
Citation: Ra. Gjerset et al., USE OF WILD-TYPE P53 TO ACHIEVE COMPLETE TREATMENT SENSITIZATION OF TUMOR-CELLS EXPRESSING ENDOGENOUS MUTANT P53, Molecular carcinogenesis, 14(4), 1995, pp. 275-285
Risultati: 1-8 |